Repository: UIHistories Project: Board of Trustees Minutes - 1980 [PAGE 113]

EXTRACTED TEXT FROM PAGE:

1978]

UNIVERSITY OF ILLINOIS

103

On motion of Mr. Livingston, authority was given as recommended.

Recommendations of the University Patent Committee

(16) T h e University Patent Committee submits the following recommendations relating to discoveries and developments by staff members. 1. First Visible Wavelength Direct Nuclear Pumped Laser — M. Alfred Akerman, formerly research assistant in nuclear engineering, Urbana, George H. Miley, professor of nuclear engineering and chairperson of Nuclear Engineering Program, Urbana, and David A. McArthur, Sandia Laboratories, Albuquerque, New Mexico, inventors; sponsored by the Department of Energy. On September 21, 1977, the Board of Trustees transferred its rights in this concept to the University of Illinois Foundation. On June 14, 1978, University Patents, Inc., elected not to service the concept under its agreement with the Foundation because "references appear to preclude generic protection" and "it docs not appear that we would ever have any hope of recovering our patent expenses." T h e Board of Directors of the Foundation on August 3, 1978, returned the patent rights to the University. It is recommended that the University retain shop rights and release all other patent rights in this concept to the sponsor, the Department of Energy. 2. Azaprostaglandin-like Drugs — Duane L. Venton, associate professor of medicinal chemistry, Medical Center, Steven Enke, graduate student in medicinal chemistry, Medical Center, and Guy C. LeBreton, assistant professor of pharmacology, Medical Center, inventors. University Patents, Inc., reported that it wishes to commercialize the invention which is a drug useful in the storage of blood platelets as well as in the prevention a n d / o r treatment of occlusive vascular disease. It is recommended that the University transfer its patent rights in the concept to the University of Illinois Foundation. 3. Z-Pro-D-Leu— Roderich Walter, professor of physiology and biophysics and head of the department, Medical Center, inventor; sponsored by the United States Department of Health, Education, and Welfare. University Patents, Inc., reported that it wishes to commercialize this invention which inhibits tolerance to and physical dependence on morphine. It is recommended that the University transfer its patent rights in this concept to the University of Illinois Foundation, subject to the rights of the sponsor, the United States Department of Health, Education, and Welfare. 4. SIMPLER System — Thomas T. Chen, assistant professor of clinical science (medical information science) in the School of Clinical Medicine, Urbana, Allan H. Levy, professor of clinical science (medical information science) in the School of Clinical Medicine, Urbana, Douglas Jones, research assistant in the School of Basic Medical Sciences, Urbana, A. B. Baskin, graduate research assistant in the School of Clinical Medicine, Urbana, and Larry Sherman, formerly assistant specialist in automated education in the School of Basic Medical Sciences, Urbana, inventors. University Patents, Inc., has agreed to license this development, a computerassisted instruction system, and the Modular Computing Corporation wishes to market it. The University Patent Committee recommends that the University release its rights in the S I M P L E R system software to the University of Illinois Foundation for marketing. I concur in these recommendations.

On motion of Mrs. Rader, these recommendations were approved.